Quantcast
Last updated on April 17, 2014 at 1:21 EDT

Drug Ups Female Libido

November 16, 2009

A medicine manufactured by German company Boehringer Ingelheim has been shown to increase a woman’s sex drive, making the group the first to launch a non-hormonal treatment for women with decreased libido.

The pill is made with flibanserin and encourages sexual cravings and increases the amount of “satisfying sexual events” in women with unusually low libido, Boehringer announced on Monday.

The results of four investigations of 2,000 pre-menopausal women plagued with Hypoactive Sexual Desire Disorder (HSDD) were offered to the public at the European Society for Sexual Medicine in Lyon, France.

Dissimilar from Procter & Gamble’s hormone patch, flibanserin quickly alters the sequence of chemical reactions in the brain thought to activate sexual desire.

“By modulating the neurotransmitter system, flibanserin may help to restore a balance between inhibitory and excitatory factors leading to a healthy sexual response,” said Elaine Jolly, a Canadian gynecologist to Reuters.

Boehringer Chief Executive Andreas Barner told German magazine WirtschaftsWoche in July that flibanserin might be on the market in a few years.

HSDD is a deficiency of the sex drive regardless partner.

Male impotence pills such like Viagra, Cialis and Levitra have not shown noteworthy aphrodisiac responses in women.

During the testing of flibanserin in the trials, the amount of pleasing sexual dealings increased to a 4.5 per month from 2.8.

Women taking the drug also reported a larger amount of sexual longing and less suffering from sexual dysfunction than those taking a placebo.

U.S. drug corporation BioSante says that the marketplace for the treatment of female sexual dysfunction runs about $2 billion in yearly sales.

On the Net: